Vanguard Group Inc. Acquires 6,393 Shares of U.S. Physical Therapy, Inc. (NYSE:USPH)

Vanguard Group Inc. increased its position in U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 0.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,084,197 shares of the company's stock after purchasing an additional 6,393 shares during the period. Vanguard Group Inc. owned 7.18% of U.S. Physical Therapy worth $96,179,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. CBIZ Investment Advisory Services LLC grew its stake in shares of U.S. Physical Therapy by 59.8% in the 4th quarter. CBIZ Investment Advisory Services LLC now owns 326 shares of the company's stock worth $29,000 after buying an additional 122 shares during the last quarter. Venturi Wealth Management LLC boosted its holdings in U.S. Physical Therapy by 3,200.0% in the fourth quarter. Venturi Wealth Management LLC now owns 726 shares of the company's stock worth $64,000 after acquiring an additional 704 shares in the last quarter. Pacer Advisors Inc. purchased a new stake in shares of U.S. Physical Therapy in the fourth quarter worth $113,000. Mutual of America Capital Management LLC purchased a new position in shares of U.S. Physical Therapy in the 4th quarter worth about $203,000. Finally, KLP Kapitalforvaltning AS bought a new position in U.S. Physical Therapy in the 4th quarter worth about $257,000.

Analyst Ratings Changes

Several analysts recently commented on USPH shares. Barrington Research cut their price objective on shares of U.S. Physical Therapy from $108.00 to $98.00 and set an "outperform" rating on the stock in a research report on Friday, February 28th. JPMorgan Chase & Co. decreased their price objective on shares of U.S. Physical Therapy from $120.00 to $110.00 and set an "overweight" rating for the company in a report on Wednesday, March 19th. JMP Securities started coverage on U.S. Physical Therapy in a report on Monday, December 16th. They issued an "outperform" rating and a $113.00 target price for the company. Citizens Jmp raised U.S. Physical Therapy to a "strong-buy" rating in a report on Monday, December 16th. Finally, Bank of America upgraded shares of U.S. Physical Therapy from a "neutral" rating to a "buy" rating and upped their target price for the company from $100.00 to $115.00 in a research note on Monday, December 16th. Two equities research analysts have rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $109.00.

Remove Ads

U.S. Physical Therapy Stock Performance

Shares of U.S. Physical Therapy stock traded down $0.70 during trading hours on Tuesday, reaching $69.15. 16,656 shares of the stock traded hands, compared to its average volume of 109,954. The company has a 50 day moving average price of $77.97 and a 200 day moving average price of $85.22. U.S. Physical Therapy, Inc. has a one year low of $62.77 and a one year high of $108.14. The company has a quick ratio of 1.78, a current ratio of 1.78 and a debt-to-equity ratio of 0.27. The firm has a market capitalization of $1.05 billion, a price-to-earnings ratio of 73.56, a P/E/G ratio of 3.54 and a beta of 1.38.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last announced its earnings results on Wednesday, February 26th. The company reported $0.65 EPS for the quarter, missing analysts' consensus estimates of $0.69 by ($0.04). The business had revenue of $180.45 million for the quarter, compared to analysts' expectations of $173.10 million. U.S. Physical Therapy had a net margin of 3.54% and a return on equity of 8.11%. On average, equities research analysts expect that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current fiscal year.

U.S. Physical Therapy Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, April 11th. Investors of record on Friday, March 14th were given a dividend of $0.45 per share. The ex-dividend date of this dividend was Friday, March 14th. This is an increase from U.S. Physical Therapy's previous quarterly dividend of $0.44. This represents a $1.80 annualized dividend and a yield of 2.60%. U.S. Physical Therapy's payout ratio is 97.83%.

Insider Buying and Selling at U.S. Physical Therapy

In other U.S. Physical Therapy news, COO Graham D. Reeve sold 1,730 shares of the company's stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $82.11, for a total value of $142,050.30. Following the completion of the transaction, the chief operating officer now directly owns 7,168 shares in the company, valued at $588,564.48. This represents a 19.44 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 1.70% of the stock is currently owned by corporate insiders.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.